Sage Therapeutics (SAGE) SEC Filings & 10K Form

$13.58
-0.42 (-3.00%)
(As of 04/25/2024 ET)

Recent Sage Therapeutics SEC Filings

DateFilerForm TypeView
04/19/2024
7:31 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
5:35 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
7:34 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
6:20 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:09 AM
RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
Form SC 13G
02/14/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:13 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/13/2024
5:28 AM
Sage Therapeutics (Subject)
Form SC 13G/A
02/13/2024
5:28 AM
BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/08/2024
9:17 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/31/2024
4:25 PM
Sage Therapeutics (Subject)
Form SC TO-I/A
01/31/2024
3:50 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:04 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
7:13 AM
Sage Therapeutics (Subject)
Form SC TO-I
01/08/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
7:30 AM
Sage Therapeutics (Filer)
Form DEF 14A
12/19/2023
7:32 AM
Sage Therapeutics (Filer)
Form DEFA14A
12/08/2023
8:00 AM
Sage Therapeutics (Subject)
Form SC TO-C
12/08/2023
7:30 AM
Sage Therapeutics (Filer)
Form PRE 14A
12/08/2023
7:30 AM
Sage Therapeutics (Filer)
Form PRE 14A
11/07/2023
6:39 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:29 AM
Sage Therapeutics (Filer)
Form 424B5
11/07/2023
6:00 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
5:46 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
7:51 AM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2023
6:20 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
7:44 AM
Sage Therapeutics (Subject)
Form SC 13G/A
07/10/2023
7:44 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
05/11/2023
7:58 AM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:21 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Mysterious Gold Leverage Just Announced (Ad)

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SAGE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners